These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35922530)

  • 1. Breast cancer stage prediction: a computational approach guided by transcriptome analysis.
    Athira K; Gopakumar G
    Mol Genet Genomics; 2022 Nov; 297(6):1467-1479. PubMed ID: 35922530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
    Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
    Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture.
    Kishore A; Venkataramana L; Prasad DVV; Mohan A; Jha B
    Med Biol Eng Comput; 2023 Nov; 61(11):2895-2919. PubMed ID: 37530887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning integrated ensemble of feature selection methods followed by survival analysis for predicting breast cancer subtype specific miRNA biomarkers.
    Sarkar JP; Saha I; Sarkar A; Maulik U
    Comput Biol Med; 2021 Apr; 131():104244. PubMed ID: 33550016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying a miRNA signature for predicting the stage of breast cancer.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2018 Oct; 8(1):16138. PubMed ID: 30382159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying cancer biomarkers by network-constrained support vector machines.
    Chen L; Xuan J; Riggins RB; Clarke R; Wang Y
    BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.
    Yao F; Zhang C; Du W; Liu C; Xu Y
    PLoS One; 2015; 10(9):e0138213. PubMed ID: 26375396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer prediction with transcriptome profiling using feature selection and machine learning methods.
    Taghizadeh E; Heydarheydari S; Saberi A; JafarpoorNesheli S; Rezaeijo SM
    BMC Bioinformatics; 2022 Oct; 23(1):410. PubMed ID: 36183055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ensemble of bioinformatics and machine learning approaches to identify shared breast cancer biomarkers among diverse populations.
    Sultan G; Zubair S
    Comput Biol Chem; 2024 Feb; 108():107999. PubMed ID: 38070457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
    Adnan N; Lei C; Ruan J
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Computational Approach for Biomarker Detection for Gene Expression-Based Computer-Aided Diagnostic Systems for Breast Cancer.
    Al-Yousef A; Samarasinghe S
    Methods Mol Biol; 2021; 2190():195-208. PubMed ID: 32804367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses.
    Yao F; Yan C; Zhang Y; Shen L; Zhou D; Ni J
    J Proteomics; 2021 Jan; 230():103991. PubMed ID: 32971305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hubness weighted SVM ensemble for prediction of breast cancer subtypes.
    Raja Sree S; Kunthavai A
    Technol Health Care; 2022; 30(3):565-578. PubMed ID: 34397436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel miRNA-based classification model of risks and stages for clear cell renal cell carcinoma patients.
    Dessie EY; Tsai JJP; Chang JG; Ng KL
    BMC Bioinformatics; 2021 May; 22(Suppl 10):270. PubMed ID: 34058987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway-based classification of cancer subtypes.
    Kim S; Kon M; DeLisi C
    Biol Direct; 2012 Jul; 7():21. PubMed ID: 22759382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA.
    Jia R; Zhao H; Jia M
    Gene; 2020 Aug; 750():144757. PubMed ID: 32387385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
    Tuo Y; An N; Zhang M
    Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma.
    Sarathi A; Palaniappan A
    BMC Cancer; 2019 Jul; 19(1):663. PubMed ID: 31277598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of breast cancer of various clinical stages based on serum FT-IR spectroscopy combined with multiple algorithms.
    Yang B; Chen C; Cheng C; Cheng H; Yan Z; Chen F; Zhu Z; Zhang H; Yue F; Lv X
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102199. PubMed ID: 33515764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.